Literature DB >> 163565

Virilizing adrenocortical adenoma responsive to gonadotrophin.

M Blichert-Toft, H Vejlsted, H Hehlet, R Albrechtsen.   

Abstract

A virilizing adrenocortical adenoma was demonstrated in a yound female. Urinary 17-ketosteroid excretion and subfractions, plasma testosterone level and urinary 17-ketogenic steroid excretion were markedly increased. Dehydroepiandrosterone was the main constituent of the androgen excess. Otherwise the adrenocortical function was found to be normal as evaluated from measurements of cortisol, corticosterone and their metabolites under basal conditions and during dynamic tests. The androgen excess showed an unexpected response to trophic hormones. Human chorionic gonadotrophin stimulation resulted in a pronounced increase in androgen production, whereas no gonadotrophin-dependency could be demonstrated by means of the oestrogen suppression test. Similarly, no corticotrophin-dependency could be demonstrated by corticotrophin stimulation and suppression tests. Removal of the tumour resulted in normalization of the androgen production and no abnormal response upon human chorionic gonadotrophin administration could now be found. The inappropriate response of tumours to trophic hormones is discussed. It is concluded that the reliability of stimulation and suppression tests in determining the site of excessive androgen production should be accepted with reservation.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 163565     DOI: 10.1530/acta.0.0780077

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  4 in total

1.  Testosterone-secreting gonadotropin-responsive adrenal adenoma and its treatment with the antiandrogen flutamide.

Authors:  F A Lószió; S Tóth; J Kocsis; M Szécsi
Journal:  J Endocrinol Invest       Date:  2001-09       Impact factor: 4.256

2.  Androgenic repression of hexobarbitone metabolism and action in Crl:CD-1 (ICR)BR mice.

Authors:  B H Shapiro; S M Szczotka
Journal:  Br J Pharmacol       Date:  1984-01       Impact factor: 8.739

3.  Virilization syndrome in a young woman due to an androgen-secreting adenoma.

Authors:  M Faggiano; T Criscuolo; A A Sinisi; A Scialdone; A Bellastella; L Cuccurullo
Journal:  J Endocrinol Invest       Date:  1984-02       Impact factor: 4.256

4.  The treatment of a hyperandrogenic and virilizing state in an elderly female with a synthetic LHRH agonist.

Authors:  J H Parr; R R Abraham; M Seed; F Short; V Wynn
Journal:  J Endocrinol Invest       Date:  1988-06       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.